================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
_______________
FORM 8-K
_______________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): April 30, 2005
BOSTON SCIENTIFIC CORPORATION
--------------------------------------------------
(Exact name of registrant as specified in charter)
DELAWARE 1-11083 04-2695240
--------------- ----------- -------------
(State or other (Commission (IRS employer
jurisdiction of file number) identification no.)
incorporation)
ONE BOSTON SCIENTIFIC PLACE, NATICK, MASSACHUSETTS 01760-1537
-------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code: (508) 650-8000
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the fling obligation of the registrant under any of the
following provisions:
[_] Written communication pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
Effective April 30, 2005, Boston Scientific Corporation reduced the
aggregate amount of commitments under its Credit and Security Agreement dated as
of August 16, 2002, as amended, by and among Boston Scientific Corporation,
Boston Scientific Funding Corporation, Blue Ridge Asset Funding Corporation,
Victory Receivables Corporations, The Bank of Tokyo-Mitsubishi Ltd., New York
Branch and Wachovia Bank, National Association from $400,000,000 in aggregate
commitments to $100,000,000 in aggregate commitments.
SIGNATURE
---------
Pursuant to the requirements of the Securities and Exchange Act of
1934, as amended, the Registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
BOSTON SCIENTIFIC CORPORATION
Date: May 4, 2005 By: /s/ Lawrence J. Knopf
---------------------------------
Lawrence J. Knopf
Vice President and Assistant
General Counsel